Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


25.06.2018

1 Ann Oncol
3 Ann Thorac Surg
1 Anticancer Res
2 BMC Cancer
1 BMJ
1 Cancer
1 Cancer Lett
6 Cancer Sci
1 Carcinogenesis
1 Clin Exp Metastasis
2 Clin Lung Cancer
1 Int J Cancer
1 Int J Oncol
2 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Thorac Cardiovasc Surg
1 Mol Carcinog
1 N Engl J Med
1 Oncol Rep
2 PLoS Comput Biol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. BONOMI PD, Gandara D, Hirsch FR, Kerr KM, et al
    Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
    Ann Oncol. 2018 Jun 14. pii: 5037893. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  2. NICASTRI DG, Alpert N, Liu B, Wolf A, et al
    Oxygen Use After Lung Cancer Surgery.
    Ann Thorac Surg. 2018 Jun 18. pii: S0003-4975(18)30848.
    PubMed     Text format     Abstract available

  3. DYAS AR, King RW, Ghanim AF, Cerfolio RJ, et al
    Clinical Mis-Stagings and Risk Factors of Occult Nodal Disease in Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2018 Jun 14. pii: S0003-4975(18)30844.
    PubMed     Text format     Abstract available

  4. SAWABATA N, Kawaguchi T, Yasukawa M, Kawai K, et al
    Recording Margin Distance Is Crucial In Limited Pulmonary Resection for Lung Cancer.
    Ann Thorac Surg. 2018 Jun 14. pii: S0003-4975(18)30842.
    PubMed     Text format    


    Anticancer Res

  5. ASANO M, Matsui J, Towle MJ, Wu J, et al
    Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven(R)): Combination with Anticancer Agents of Differing Mechanisms.
    Anticancer Res. 2018;38:3375-3385.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. TIAN X, Ma J, Wang T, Tian J, et al
    Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer.
    BMC Cancer. 2018;18:660.
    PubMed     Text format     Abstract available

  7. WANG Q, Cheng Y, Wang Y, Fan Y, et al
    Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    BMC Cancer. 2017;17:492.
    PubMed     Text format     Abstract available


    BMJ

  8. CRAWFORD SM
    Multidisciplinary team working contributes to lung cancer survival.
    BMJ. 2018;361:k1904.
    PubMed     Text format    


    Cancer

  9. PATEL JD, Chmura SJ
    Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31557.
    PubMed     Text format    


    Cancer Lett

  10. LU Z, Li Y, Che Y, Huang J, et al
    The TGFbeta-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Cancer Lett. 2018;432:156-168.
    PubMed     Text format     Abstract available


    Cancer Sci

  11. WANG H, Zhang G
    Endoplasmic reticulum stress-mediated autophagy protects against beta,beta-dimethylacrylshikonin-induced apoptosis in lung adenocarcinoma cells.
    Cancer Sci. 2018;109:1889-1901.
    PubMed     Text format     Abstract available

  12. ALAEE M, Nool K, Pasdar M
    Plakoglobin restores tumor suppressor activity of p53(R175H) mutant by sequestering the oncogenic potential of beta-catenin.
    Cancer Sci. 2018;109:1876-1888.
    PubMed     Text format     Abstract available

  13. FENG W, Xie Q, Liu S, Ji Y, et al
    Kruppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer.
    Cancer Sci. 2018;109:1775-1786.
    PubMed     Text format     Abstract available

  14. LI S, Ma F, Jiang K, Shan H, et al
    Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 promotes lung adenocarcinoma by directly interacting with specificity protein 1.
    Cancer Sci. 2018;109:1346-1356.
    PubMed     Text format     Abstract available

  15. LIU K, Gao H, Wang Q, Wang L, et al
    Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer.
    Cancer Sci. 2018;109:1369-1381.
    PubMed     Text format     Abstract available

  16. SEMBA T, Sugihara E, Kamoshita N, Ueno S, et al
    Periostin antisense oligonucleotide suppresses bleomycin-induced formation of a lung premetastatic niche for melanoma.
    Cancer Sci. 2018;109:1447-1454.
    PubMed     Text format     Abstract available


    Carcinogenesis

  17. BYUN J, Schwartz AG, Lusk C, Wenzlaff AS, et al
    Genome-Wide Association Study of Familial Lung Cancer.
    Carcinogenesis. 2018 Jun 19. pii: 5040139. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  18. MILLIEN G, Cao Y, O'Hara CJ, Tagne JB, et al
    ETS1 regulates Twist1 transcription in a Kras (G12D) /Lkb1(-/-) metastatic lung tumor model of non-small cell lung cancer.
    Clin Exp Metastasis. 2018 Jun 16. pii: 10.1007/s10585-018-9912.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  19. RAMAN S, Bissonnette JP, Warner A, Le L, et al
    Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).
    Clin Lung Cancer. 2018 May 16. pii: S1525-7304(18)30107.
    PubMed     Text format     Abstract available

  20. HIRSH V, Wan Y, Lin FJ, Margunato-Debay S, et al
    Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30105.
    PubMed     Text format     Abstract available


    Int J Cancer

  21. LUU HN, Cai H, Murff HJ, Xiang YB, et al
    A Prospective Study of Dietary Polyunsaturated Fatty Acids Intake and Lung Cancer Risk.
    Int J Cancer. 2018 Jun 15. doi: 10.1002/ijc.31608.
    PubMed     Text format     Abstract available


    Int J Oncol

  22. LUO X, Ye S, Jiang Q, Gong Y, et al
    Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/beta-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
    Int J Oncol. 2018 Jun 15. doi: 10.3892/ijo.2018.4442.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  23. JOHNSON CN, Price GJ, Faivre-Finn C, Aznar MC, et al
    Residual setup errors towards the heart after image guidance linked with poorer survival in lung cancer patients: do we need stricter IGRT protocols?
    Int J Radiat Oncol Biol Phys. 2018 Jun 1. pii: S0360-3016(18)30904.
    PubMed     Text format     Abstract available

  24. BANG A, Kendal WS, Laurie SA, Cook G, et al
    Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre.
    Int J Radiat Oncol Biol Phys. 2018 May 1. pii: S0360-3016(18)30736.
    PubMed     Text format     Abstract available


    J Clin Oncol

  25. PIETANZA MC, Waqar SN, Krug LM, Dowlati A, et al
    Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
    J Clin Oncol. 2018 Jun 15:JCO2018777672. doi: 10.1200/JCO.2018.77.7672.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  26. UPHAM TC, Onaitis MW
    Video-assisted thoracoscopic surgery versus robot-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;156:365-368.
    PubMed     Text format    


    Mol Carcinog

  27. WU GJ, Pen J, Huang Y, An S, et al
    KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells.
    Mol Carcinog. 2018 Jun 19. doi: 10.1002/mc.22853.
    PubMed     Text format     Abstract available


    N Engl J Med

  28. SOCINSKI MA, Jotte RM, Cappuzzo F, Orlandi F, et al
    Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
    N Engl J Med. 2018;378:2288-2301.
    PubMed     Text format     Abstract available


    Oncol Rep

  29. ZHANG L, Qi Y, Xing K, Qian S, et al
    A novel strategy of EGFRTKI combined chemotherapy in the treatment of human lung cancer with EGFRsensitive mutation.
    Oncol Rep. 2018 Jun 18. doi: 10.3892/or.2018.6499.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  30. SUN JX, He Y, Sanford E, Montesion M, et al
    A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    PLoS Comput Biol. 2018;14:e1005965.
    PubMed     Text format     Abstract available

  31. MCDOWELL IC, Manandhar D, Vockley CM, Schmid AK, et al
    Clustering gene expression time series data using an infinite Gaussian process mixture model.
    PLoS Comput Biol. 2018;14:e1005896.
    PubMed     Text format     Abstract available


    PLoS One

  32. HSIEH LY, Chou FJ, Guo SE
    Information needs of patients with lung cancer from diagnosis until first treatment follow-up.
    PLoS One. 2018;13:e0199515.
    PubMed     Text format     Abstract available

  33. DANISH L, Imig D, Allgower F, Scheurich P, et al
    Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps.
    PLoS One. 2018;13:e0198203.
    PubMed     Text format     Abstract available

  34. BLUME JD, D'Agostino McGowan L, Dupont WD, Greevy RA Jr, et al
    Second-generation p-values: Improved rigor, reproducibility, & transparency in statistical analyses.
    PLoS One. 2018;13:e0188299.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: